Effect of penile rehabilitation with low intensity extracorporeal shock wave therapy on erectile function recovery following robot-assisted laparoscopic prostatectomy.

Low intensity extracorporeal shock wave therapy (LIESWT) penile rehabilitation radical prostatectomy sexual function

Journal

Translational andrology and urology
ISSN: 2223-4691
Titre abrégé: Transl Androl Urol
Pays: China
ID NLM: 101581119

Informations de publication

Date de publication:
Aug 2020
Historique:
entrez: 18 9 2020
pubmed: 19 9 2020
medline: 19 9 2020
Statut: ppublish

Résumé

Considering the natural course of cavernous nerve recovery after robot-assisted laparoscopic prostatectomy (RALP), early intervention of low intensity extracorporeal shock wave therapy (LIESWT) would be more effective for enhancing overall recovery of sexual function (SF). Our objective of this study is to analyze longitudinally the alterations of SF in patients after RALP, with a focus on the effect of early and delayed intervention with LIESWT. A total of 5 and 11 patients underwent early and delayed intervention with LIESWT, respectively. SF was assessed with the Expanded Prostate Cancer Index Composite (EPIC). The same surgeon performed RALP on 178 patients, and these patients were assigned to the non-LIESWT group to establish a control group. The SF score of EPIC was investigated longitudinally before RALP and 3, 6, 9, and 12 months after RALP. Our results show that penile rehabilitation with LIESWT immediately before urethral catheter removal improved SF scores. In the baseline, the SF score was significantly higher in the early LIESWT group (P=0.0001). The SF score was significantly lower at postoperative 6 months (early 19.2, delayed 17.9, and non-LIESWT 8.1; P=0.0171), 9 months (20.9, 25.8, and 10.2; P=0.0188), and 12 months (28.0, 21.3, and 9.5; P=0.0051) in the non-LIESWT group. We regret that there was no significant difference in the recovery of SF between the early and delayed protocol with LIESWT at all points. In keeping with our results, LIESWT demonstrated the potential to be efficacious in treatment options for severe post-radical prostatectomy (RP) erectile dysfunction (ED) as it may indirectly support its promotion of nerve regeneration in severe ED due to RP. This is the first study in which LIESWT has been shown to deliver a clinical benefit on its early or delayed intervention to patients after RALP to penile rehabilitation in terms of restoring SF. Our preliminary results suggest that LIESWT could be used as a treatment option in penile rehabilitation.

Sections du résumé

BACKGROUNDS BACKGROUND
Considering the natural course of cavernous nerve recovery after robot-assisted laparoscopic prostatectomy (RALP), early intervention of low intensity extracorporeal shock wave therapy (LIESWT) would be more effective for enhancing overall recovery of sexual function (SF). Our objective of this study is to analyze longitudinally the alterations of SF in patients after RALP, with a focus on the effect of early and delayed intervention with LIESWT.
METHODS METHODS
A total of 5 and 11 patients underwent early and delayed intervention with LIESWT, respectively. SF was assessed with the Expanded Prostate Cancer Index Composite (EPIC). The same surgeon performed RALP on 178 patients, and these patients were assigned to the non-LIESWT group to establish a control group. The SF score of EPIC was investigated longitudinally before RALP and 3, 6, 9, and 12 months after RALP.
RESULTS RESULTS
Our results show that penile rehabilitation with LIESWT immediately before urethral catheter removal improved SF scores. In the baseline, the SF score was significantly higher in the early LIESWT group (P=0.0001). The SF score was significantly lower at postoperative 6 months (early 19.2, delayed 17.9, and non-LIESWT 8.1; P=0.0171), 9 months (20.9, 25.8, and 10.2; P=0.0188), and 12 months (28.0, 21.3, and 9.5; P=0.0051) in the non-LIESWT group. We regret that there was no significant difference in the recovery of SF between the early and delayed protocol with LIESWT at all points. In keeping with our results, LIESWT demonstrated the potential to be efficacious in treatment options for severe post-radical prostatectomy (RP) erectile dysfunction (ED) as it may indirectly support its promotion of nerve regeneration in severe ED due to RP.
CONCLUSIONS CONCLUSIONS
This is the first study in which LIESWT has been shown to deliver a clinical benefit on its early or delayed intervention to patients after RALP to penile rehabilitation in terms of restoring SF. Our preliminary results suggest that LIESWT could be used as a treatment option in penile rehabilitation.

Identifiants

pubmed: 32944518
doi: 10.21037/tau-19-888
pii: tau-09-04-1559
pmc: PMC7475683
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1559-1565

Informations de copyright

2020 Translational Andrology and Urology. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/ tau-19-888). The authors have no conflicts of interest to declare.

Références

Curr Drug Targets. 2015;16(5):459-73
pubmed: 25777276
Otolaryngol Clin North Am. 2009 Dec;42(6):1139-59, Table of Contents
pubmed: 19962012
Dig Endosc. 2010 Jul;22 Suppl 1:S76-8
pubmed: 20590777
Eur Urol. 2012 Sep;62(3):405-17
pubmed: 22749852
Int J Impot Res. 2018 Feb;30(1):1-7
pubmed: 29180799
Lancet. 1980 Dec 13;2(8207):1265-8
pubmed: 6108446
World J Mens Health. 2016 Aug;34(2):73-88
pubmed: 27574591
BJU Int. 2009 Oct;104(8):1077-84
pubmed: 19338553
J Urol. 2005 May;173(5):1673-6
pubmed: 15821546
J Sex Med. 2012 Jan;9(1):259-64
pubmed: 22008059
J Sex Med. 2016 Jan;13(1):22-32
pubmed: 26755082
Eur Urol. 2010 Aug;58(2):243-8
pubmed: 20451317
Urol Clin North Am. 2007 Nov;34(4):601-18, viii
pubmed: 17983900
World J Gastroenterol. 2011 Oct 21;17(39):4365-71
pubmed: 22110261
J Urol. 2000 Dec;164(6):1929-34
pubmed: 11061884
Wound Repair Regen. 2009 Jul-Aug;17(4):522-30
pubmed: 19614917
Circulation. 2004 Nov 9;110(19):3055-61
pubmed: 15520304
Cancer. 2002 Oct 15;95(8):1773-85
pubmed: 12365027
BJU Int. 2013 Nov;112(7):998-1008
pubmed: 23826962
J Sex Med. 2010 Jan;7(1 Pt 2):524-40
pubmed: 20092451
World J Mens Health. 2013 Dec;31(3):208-14
pubmed: 24459653
Foot Ankle Int. 2011 Aug;32(8):746-54
pubmed: 22049860
Ultrasonics. 1994 Sep;32(5):397-400
pubmed: 8079400
Urology. 2016 Feb;88:226.e1-9
pubmed: 26522972
J Sex Med. 2010 Nov;7(11):3572-88
pubmed: 21040491
Urology. 2000 Jan;55(1):58-61
pubmed: 10654895
J Sex Med. 2014 Dec;11(12):2903-14
pubmed: 25302850
Ortop Traumatol Rehabil. 2007 May-Jun;9(3):254-8
pubmed: 17721422
J Urol. 2018 Jun;199(6):1600-1606
pubmed: 29307683

Auteurs

Shogo Inoue (S)

Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Tetsutaro Hayashi (T)

Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Jun Teishima (J)

Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Akio Matsubara (A)

Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Classifications MeSH